Jacobio Pharmaceuticals Group Co., Ltd.
HKEX:1167.HK
8.11 (HKD) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 155.708 | 63.52 | 95.746 | 152.809 | 486.286 | 0 | 0 |
| Cost of Revenue
| 0 | 60.317 | 83.112 | 139.979 | 44.115 | 0 | 0 |
| Gross Profit
| 155.708 | 3.203 | 12.634 | 12.83 | 442.171 | 0 | 0 |
| Gross Profit Ratio
| 1 | 0.05 | 0.132 | 0.084 | 0.909 | 0 | 0 |
| Reseach & Development Expenses
| 330.177 | 372.32 | 445.647 | 280.838 | 185.952 | 138.976 | 84.887 |
| General & Administrative Expenses
| 43.051 | 46.615 | 42.551 | 16.88 | 53.838 | 3.043 | 5.911 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 43.051 | 46.615 | 42.551 | 16.88 | 53.838 | 3.043 | 5.911 |
| Other Expenses
| -29.347 | -17.854 | -0.83 | 17.436 | -7.009 | 58.417 | -52.905 |
| Operating Expenses
| 343.881 | 401.081 | 487.368 | 315.154 | 232.781 | 200.436 | 105.295 |
| Operating Income
| -188.173 | -397.878 | -474.734 | -302.324 | 179.111 | -194.17 | -101.433 |
| Operating Income Ratio
| -1.208 | -6.264 | -4.958 | -1.978 | 0.368 | 0 | 0 |
| Total Other Income Expenses Net
| 32.464 | 38.759 | 22.34 | 18.197 | -1,692.788 | -231.647 | -54.502 |
| Income Before Tax
| -155.709 | -359.119 | -371.861 | -301.187 | -1,513.677 | -425.817 | -155.935 |
| Income Before Tax Ratio
| -1 | -5.654 | -3.884 | -1.971 | -3.113 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 3.022 | -8.9 | 1,694.852 | 0 | 0 |
| Net Income
| -155.709 | -359.119 | -374.883 | -292.287 | -3,208.529 | -661.79 | -149.212 |
| Net Income Ratio
| -1 | -5.654 | -3.915 | -1.913 | -6.598 | 0 | 0 |
| EPS
| -0.2 | -0.46 | -0.5 | -0.39 | -4.26 | -0.87 | -0.2 |
| EPS Diluted
| -0.2 | -0.46 | -0.5 | -0.39 | -4.26 | -0.87 | -0.2 |
| EBITDA
| -192.356 | -325.727 | -355.796 | -289.828 | -1,504.309 | -175.651 | -92.376 |
| EBITDA Ratio
| -1.235 | -5.128 | -3.716 | -1.897 | -3.093 | 0 | 0 |